KINDLIA
Amgen Inc.
Mark For: KINDLIA™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88517655 |
| Mark Literal Elements | KINDLIA |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-02-20 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Timothy J. Gaul |
| Attorney Docket Number | TM-1441-US-2 |
| Law Office Assigned | N80 |
| Employee Name | KLUWE, CHERYL D |
Timeline
| 2019-07-16 | Application Filed |
| 2019-09-03 | Location: TMO LAW OFFICE 126- EXAMINING ATTORNEY ASSIGNED |
| 2019-09-03 | Status: Live/Pending |
| 2019-09-03 | Transaction Date |
| 2020-02-20 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-02-20 | Status: Review prior to publication completed. |
| 2020-03-24 | Published |
Trademark Parties (Applicants & Owners)
| Party: |  Amgen Inc. |
| Address | Trademark Operations - MS-28-5A One Amgen Center Drive Thousand Oaks, CALIFORNIA UNITED STATES 913201799 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | IMAGE/JPEG | 2019-07-16 |
 TEAS RF New Application | MULTI | 2019-07-16 |
| Notation to File | XML | 2019-09-03 |
| Offc Action Outgoing | XML | 2019-09-03 |
| XSearch Search Summary | APPLICATION/XML | 2019-09-03 |
| Response to Office Action | XML | 2020-02-05 |
| Amendment and Mail Process Complete | MULTI | 2020-02-07 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-02-11 |
| Notice of Publication | XML | 2020-03-04 |
| Notification Of Notice of Publication | XML | 2020-03-04 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders; pharmaceuticals for stimulating the growth of platelets and platelet precursor cells; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of bone disease; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations; pharmaceutical preparations used for the treatment of parathyroid, glandular and hormone disorders; pharmaceutical preparations used for the treatment of renal and kidney disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders, hematological diseases and disorders, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders; pharmaceuticals for stimulating the growth of platelets and platelet precursor cells; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for modulating the level of calcium in the bloodstream and for the treatment of hyperparathyroidism and hypercalcemia; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of bone disease; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-03-04 | |
| ASSIGNED TO LIE | 2020-02-18 | 68171 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-02-10 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-06 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-02-05 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-05 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-09-03 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-09-03 | 93980 |
| NON-FINAL ACTION E-MAILED | 2019-09-03 | 6325 |
| ASSIGNED TO EXAMINER | 2019-08-26 | 93980 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-07-24 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-07-19 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KINDLIA 88517655 not registered Live/Pending |
Amgen Inc. 2019-07-16 |
 KINDLIA 86665895 not registered Dead/Abandoned |
Amgen Inc. 2015-06-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 